Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201710059014N191Phase 2Completed
Phase 2, open-label trial of acetaminophen, pethidine and ibuprofen in acute cholecystitis (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Severity of pain. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201710059014N191.